GlmS plays a key role in the virulence factor expression and biofilm formation ability of Staphylococcus aureus promoted by advanced glycation end products
is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA rele...
Saved in:
Published in | Virulence Vol. 15; no. 1; p. 2352476 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.12.2024
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via
upregulation in
, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of
in
stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of
. We constructed NCTC 8325 ∆
for further validation. qRT-PCR analysis revealed that AGEs promoted both
and
expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆
. NCTC 8325 ∆
showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in
expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of
and
expression, and less and sparser biofilms, indicated that
and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆
. Our data extend the understanding of GlmS in the global regulatory network of
and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates
and plays a significant role in mediating biofilm formation and virulence factor expression. |
---|---|
AbstractList | Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression. Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression.Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression. is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via upregulation in , contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of in stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of . We constructed NCTC 8325 ∆ for further validation. qRT-PCR analysis revealed that AGEs promoted both and expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆ . NCTC 8325 ∆ showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of and expression, and less and sparser biofilms, indicated that and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆ . Our data extend the understanding of GlmS in the global regulatory network of and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates and plays a significant role in mediating biofilm formation and virulence factor expression. Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus , contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB . We constructed NCTC 8325 ∆ glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆ glmS . NCTC 8325 ∆ glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆ glmS . Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression. |
Author | Deng, Yawen Luo, Hua Ni, Lijia Shen, Rui Li, Xuexue Huang, Lisi Wu, Yonglin Duan, Chaohui Zhang, Xiaofan Liao, Xiaoyan Xie, Xiaoying |
Author_xml | – sequence: 1 givenname: Lijia surname: Ni fullname: Ni, Lijia organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 2 givenname: Rui surname: Shen fullname: Shen, Rui organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 3 givenname: Hua surname: Luo fullname: Luo, Hua organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 4 givenname: Xuexue surname: Li fullname: Li, Xuexue organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 5 givenname: Xiaofan surname: Zhang fullname: Zhang, Xiaofan organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 6 givenname: Lisi surname: Huang fullname: Huang, Lisi organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 7 givenname: Yawen surname: Deng fullname: Deng, Yawen organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 8 givenname: Xiaoyan surname: Liao fullname: Liao, Xiaoyan organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 9 givenname: Yonglin surname: Wu fullname: Wu, Yonglin organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 10 givenname: Chaohui orcidid: 0000-0003-3130-5045 surname: Duan fullname: Duan, Chaohui organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 11 givenname: Xiaoying orcidid: 0000-0002-6113-6505 surname: Xie fullname: Xie, Xiaoying organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38741276$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkstu1TAQhiNUREvpI4C8ZHOKHV-SiAVCFZRKlVgU1pZjj89xceJgOxV5Fl4Wn1tF2eCFxxr__ze2Zl5WJ2MYoapeE3xJcIvf1YRjzjt2WeO6bJTXrBHPqrNtfsUFbk-O5yI6rS5SusdlsZYU24vqlLYNI3Ujzqrf1364Q5NXS0IK_YAFxeABuRHlDaAHF2cPowZklc4hIvg1RUjJhRGp0aDeBev8gGyIg8q7bO-8ywsKFt1lNW0WH3TQei70OUIJUwxDyFC8C1LmQRW4QWu_6L0fCrVIzKxzelU9t8onuDjE8-r750_frr6sbr9e31x9vF1p1rR5ZbsOOsyZbijrrebCmEYYaygwZhtjTM8b1fQUQ0-IUBao6RotKDGCcVsbel7d7LkmqHs5RTeouMignNwlQlxLFbPTHqSoe00o6BYTYIKbjoPQUDNiFe570hXWhz1rmvsBjIYxR-WfQJ_ejG4j1-FBEoI7zhtWCG8PhBh-zpCyHFzS4L0aIcxJ0vLVlna8JkX65u9ij1WO7S0CvhfoGFKKYB8lBMvtJMnjJMntJMnDJBXf-3982uVdg8qbnf-P-w-RXtHo |
CitedBy_id | crossref_primary_10_5306_wjco_v15_i9_1117 crossref_primary_10_1021_acscentsci_4c01167 crossref_primary_10_3390_amh70010009 |
Cites_doi | 10.3389/fcimb.2019.00157 10.1126/science.1153018 10.1093/humrep/det419 10.1021/cb200016d 10.1007/BF00282455 10.1167/iovs.63.6.25 10.3389/fpls.2022.948751 10.3390/cells11081312 10.1002/chem.202202378 10.3892/ol.2017.7127 10.1007/978-1-0716-1550-8_9 10.1016/j.plasmid.2005.05.005 10.1128/JB.01000-07 10.3389/fcimb.2015.00001 10.1038/s41426-018-0078-1 10.3389/fmicb.2022.967567 10.4161/viru.2.5.17724 10.1016/j.biomaterials.2012.05.031 10.1007/s11892-013-0453-1 10.1152/ajpcell.00267.2021 10.1016/j.intimp.2021.107806 10.1002/eji.201948477 10.1021/ar200039b 10.1111/lam.13456 10.1016/j.ijfoodmicro.2021.109499 10.3390/cells11142178 10.7554/eLife.54983 10.1093/nar/gkab1038 10.1017/S0033583510000144 10.3389/fmicb.2020.01479 10.1111/j.1365-2958.2004.04200.x 10.1016/j.jhep.2021.08.027 10.2174/0929866526666190822162140 10.1007/s11274-021-03004-7 10.3389/fmicb.2021.672943 10.1021/acssynbio.1c00443 10.1038/s41598-020-78379-y 10.1126/science.1129666 10.1155/2017/8694903 10.1261/rna.2590811 10.1016/0378-1119(95)00732-6 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) |
Copyright_xml | – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1080/21505594.2024.2352476 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | L. NI ET AL |
EISSN | 2150-5608 |
ExternalDocumentID | oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19 PMC11095574 38741276 10_1080_21505594_2024_2352476 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 82002203] – fundername: Basic and Applied Basic Research Foundation of Guangdong Province grantid: 2023A1515010089 |
GroupedDBID | --- 0YH 53G AAYXX ABDBF ABPEM ACGFS ACUHS ADBBV ADCVX AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION EBS EMOBN ESX F5P GROUPED_DOAJ GTTXZ H13 HZ~ O9- OK1 RPM SV3 TDBHL TFL TFW TR2 TUS 4.4 ABCCY C1A CGR CUY CVF DGEBU DIK ECM EIF EJD HYE M4Z NPM OVD TEORI TTHFI 7X8 5PM |
ID | FETCH-LOGICAL-c478t-f99e9054c734bfc56dd76dfd3e44f7dddb57a7b30eb116afe3d97c631d645f2d3 |
IEDL.DBID | DOA |
ISSN | 2150-5594 2150-5608 |
IngestDate | Wed Aug 27 01:11:24 EDT 2025 Thu Aug 21 18:35:43 EDT 2025 Thu Jul 10 17:00:58 EDT 2025 Sat Mar 01 01:25:46 EST 2025 Tue Jul 01 01:22:34 EDT 2025 Thu Apr 24 22:53:09 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | GlmS-sigB regulatory axis biofilm formation advanced glycation end products virulence factor expression Staphylococcus aureus |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-f99e9054c734bfc56dd76dfd3e44f7dddb57a7b30eb116afe3d97c631d645f2d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0002-6113-6505 0000-0003-3130-5045 |
OpenAccessLink | https://doaj.org/article/62bc13ec801e465d95e6ce241fa0bb19 |
PMID | 38741276 |
PQID | 3054839521 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11095574 proquest_miscellaneous_3054839521 pubmed_primary_38741276 crossref_primary_10_1080_21505594_2024_2352476 crossref_citationtrail_10_1080_21505594_2024_2352476 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-00 |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Virulence |
PublicationTitleAlternate | Virulence |
PublicationYear | 2024 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_7_40_1 e_1_3_7_41_1 e_1_3_7_21_1 e_1_3_7_44_1 e_1_3_7_20_1 e_1_3_7_23_1 e_1_3_7_42_1 e_1_3_7_22_1 e_1_3_7_43_1 e_1_3_7_25_1 e_1_3_7_27_1 e_1_3_7_26_1 e_1_3_7_29_1 e_1_3_7_28_1 Liu H (e_1_3_7_30_1) 2018; 7 Li Z (e_1_3_7_15_1) 2020; 39 Zhang L (e_1_3_7_24_1) 2022; 10 e_1_3_7_32_1 e_1_3_7_10_1 e_1_3_7_31_1 e_1_3_7_11_1 e_1_3_7_34_1 e_1_3_7_12_1 e_1_3_7_33_1 e_1_3_7_13_1 e_1_3_7_36_1 e_1_3_7_14_1 e_1_3_7_35_1 e_1_3_7_38_1 e_1_3_7_16_1 e_1_3_7_37_1 e_1_3_7_17_1 e_1_3_7_18_1 e_1_3_7_39_1 e_1_3_7_19_1 e_1_3_7_3_1 e_1_3_7_2_1 e_1_3_7_5_1 e_1_3_7_4_1 e_1_3_7_7_1 e_1_3_7_6_1 e_1_3_7_9_1 e_1_3_7_8_1 |
References_xml | – ident: e_1_3_7_26_1 doi: 10.3389/fcimb.2019.00157 – ident: e_1_3_7_44_1 doi: 10.1126/science.1153018 – ident: e_1_3_7_7_1 doi: 10.1093/humrep/det419 – ident: e_1_3_7_36_1 doi: 10.1021/cb200016d – ident: e_1_3_7_10_1 doi: 10.1007/BF00282455 – ident: e_1_3_7_20_1 doi: 10.1167/iovs.63.6.25 – ident: e_1_3_7_25_1 doi: 10.3389/fpls.2022.948751 – ident: e_1_3_7_39_1 doi: 10.3390/cells11081312 – ident: e_1_3_7_14_1 doi: 10.1002/chem.202202378 – ident: e_1_3_7_19_1 doi: 10.3892/ol.2017.7127 – ident: e_1_3_7_29_1 doi: 10.1007/978-1-0716-1550-8_9 – ident: e_1_3_7_23_1 doi: 10.1016/j.plasmid.2005.05.005 – ident: e_1_3_7_22_1 doi: 10.1128/JB.01000-07 – ident: e_1_3_7_5_1 doi: 10.3389/fcimb.2015.00001 – volume: 7 start-page: 1 year: 2018 ident: e_1_3_7_30_1 article-title: A novel SigB(Q225P) mutation in Staphylococcus aureus retains virulence but promotes biofilm formation publication-title: Emerg Microbes Infect doi: 10.1038/s41426-018-0078-1 – ident: e_1_3_7_32_1 doi: 10.3389/fmicb.2022.967567 – ident: e_1_3_7_2_1 doi: 10.4161/viru.2.5.17724 – ident: e_1_3_7_3_1 doi: 10.1016/j.biomaterials.2012.05.031 – ident: e_1_3_7_6_1 doi: 10.1007/s11892-013-0453-1 – ident: e_1_3_7_21_1 doi: 10.1152/ajpcell.00267.2021 – ident: e_1_3_7_41_1 doi: 10.1016/j.intimp.2021.107806 – ident: e_1_3_7_8_1 doi: 10.1002/eji.201948477 – ident: e_1_3_7_12_1 doi: 10.1021/ar200039b – ident: e_1_3_7_33_1 doi: 10.1111/lam.13456 – volume: 39 start-page: 1 issue: 1 year: 2020 ident: e_1_3_7_15_1 article-title: Targeting HMGB3/hTERT axis for radioresistance in cervical cancer publication-title: J Exp Clin Cancer Res [internet] – ident: e_1_3_7_31_1 doi: 10.1016/j.ijfoodmicro.2021.109499 – ident: e_1_3_7_40_1 doi: 10.3390/cells11142178 – ident: e_1_3_7_16_1 doi: 10.7554/eLife.54983 – ident: e_1_3_7_17_1 doi: 10.1093/nar/gkab1038 – ident: e_1_3_7_11_1 doi: 10.1017/S0033583510000144 – ident: e_1_3_7_9_1 doi: 10.3389/fmicb.2020.01479 – ident: e_1_3_7_13_1 doi: 10.1111/j.1365-2958.2004.04200.x – ident: e_1_3_7_38_1 doi: 10.1016/j.jhep.2021.08.027 – volume: 10 start-page: e00363 issue: 4 year: 2022 ident: e_1_3_7_24_1 article-title: Development and application of two inducible expression systems for Streptococcus suis publication-title: Microbiol Spectr [Internet] – ident: e_1_3_7_18_1 doi: 10.2174/0929866526666190822162140 – ident: e_1_3_7_42_1 doi: 10.1007/s11274-021-03004-7 – ident: e_1_3_7_28_1 doi: 10.3389/fmicb.2021.672943 – ident: e_1_3_7_35_1 doi: 10.1021/acssynbio.1c00443 – ident: e_1_3_7_27_1 doi: 10.1038/s41598-020-78379-y – ident: e_1_3_7_37_1 doi: 10.1126/science.1129666 – ident: e_1_3_7_4_1 doi: 10.1155/2017/8694903 – ident: e_1_3_7_43_1 doi: 10.1261/rna.2590811 – ident: e_1_3_7_34_1 doi: 10.1016/0378-1119(95)00732-6 |
SSID | ssj0000481055 |
Score | 2.3945475 |
Snippet | is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that... Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We... Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2352476 |
SubjectTerms | advanced glycation end products Bacterial Proteins - genetics Bacterial Proteins - metabolism biofilm formation Biofilms - growth & development Gene Expression Regulation, Bacterial GlmS-sigB regulatory axis Glycation End Products, Advanced - metabolism Humans Sigma Factor - genetics Sigma Factor - metabolism Staphylococcal Infections - microbiology Staphylococcus aureus Staphylococcus aureus - genetics Staphylococcus aureus - pathogenicity virulence factor expression Virulence Factors - genetics |
Title | GlmS plays a key role in the virulence factor expression and biofilm formation ability of Staphylococcus aureus promoted by advanced glycation end products |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38741276 https://www.proquest.com/docview/3054839521 https://pubmed.ncbi.nlm.nih.gov/PMC11095574 https://doaj.org/article/62bc13ec801e465d95e6ce241fa0bb19 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB50QfBFvFsvyxF8rdtkbsmjimsR9EUX1qcwVy1009I2Yn6Lf9ZzZpLSirAvQkhgkkmGnDNnvknOfB9jr6IR3BhOCU-VwgkKurHRUmAwjFwq7euQPl18-qzmF-Ljpbw8kPqinLBMD5xf3JkqrSt4cBhJg1DS1zKQiJUooplZmwg_SxzzDiZTKQaLipQfSVkOEc8UYbMYl-9UszMqoyKcHpa4QwwiiHPkYGBK_P3_Ap1_504eDEbnd9mdAUXCm9z6e-xGaO-zW1lXsn_Afn9YXn2B9dL0WzCA3RQoiRAWLSDcg5-LTZeWGkEW24Hwa8iGbcG0HuyCZLyvYL-uETKXdw-rCAhO0TA4Aq6c6_Du3SbgYZ2S-gLW7WHMKoDvyz5_D4SAd11natntQ3Zx_v7ru_l0UGGYOqGr3TTWaC8Edk5zYaOTynutfPQ8CBG1995KbbTlM4z6hTIxcF9rp3jhlZCx9PwRO2lXbXjCoPRS4xaF9oUwtUPzaRO9tBhVoi7KCROjCRo3UJSTUsayKQYm09FyDVmuGSw3Ya_31daZo-O6Cm_JvvuLiWI7FaDjNYPjNdc53oS9HL2jwS5J_1lMG1bdtsEQKhB3IjCasMfZW_aP4hVCuJKaUB350VFbjs-0ix-J9pu4YaXU4un_aP0zdpveSE7Mec5OdpsuvEB4tbOn7Obs2_w09ac_SLAiKA |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GlmS+plays+a+key+role+in+the+virulence+factor+expression+and+biofilm+formation+ability+of+Staphylococcus+aureus+promoted+by+advanced+glycation+end+products&rft.jtitle=Virulence&rft.au=Lijia+Ni&rft.au=Rui+Shen&rft.au=Hua+Luo&rft.au=Xuexue+Li&rft.date=2024-12-01&rft.pub=Taylor+%26+Francis+Group&rft.issn=2150-5594&rft.eissn=2150-5608&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1080%2F21505594.2024.2352476&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-5594&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-5594&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-5594&client=summon |